BJUI Mini Reviews - Targeted Therapies in Metastatic Renal Cancer in 2009
This review assesses published reports on four targeted therapies (bevacizumab, sunitinib, sorafenib and temsirolimus) for the treatment of metastatic clear cell renal cell carcinoma.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |





